Amplia Therapeutics: Advancing Pancreatic Cancer Treatment

Amplia clinical trial has seen "confirmed responses" among pancreatic cancer patientsПодробнее

Amplia Therapeutics moves to next phase of pancreatic cancer treatment trialПодробнее

Amplia Therapeutics Talks To JustStocks About Recruitment Milestone for Pancreatic Cancer TrialПодробнее

Amplia Therapeutics in preclinical collaboration with Next&BioПодробнее

How is locally advanced pancreatic cancer treated? - Online interviewПодробнее

Amplia free to proceed with phase two pancreatic cancer trialПодробнее

10warning signs of pancreatic cancer that will shock you|Pancreatic cancer symptomsПодробнее

Amplia Therapeutics achieves critical clinical milestone for lead cancer therapyПодробнее

Amplia Therapeutics develops new approach to treat cancer and fibrosisПодробнее

CONKO-007: chemoradiotherapy increases rates of R0 resection in locally advanced pancreatic cancerПодробнее

Important decisions for patients with advanced pancreatic cancer videoПодробнее

Locally Advanced Pancreatic Cancer: Optimizing TreatmentПодробнее

Improving responses to immunotherapy in metastatic pancreatic cancerПодробнее

Optimizing Treatment of Advanced Pancreatic CancerПодробнее

Treatment Approaches for Pancreatic CancerПодробнее

Adjuvant Therapy in Locally Advanced Pancreatic CancerПодробнее

Treatment for Locally Advanced Pancreatic CancerПодробнее

Advancing Outcomes in Pancreatic CancerПодробнее

Pancreatic Cancer Treatment at Penn MedicineПодробнее